BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 17491264)

  • 1. [Symptomatic evaluation of late onset hypogonadism in healthy Chinese men].
    Li JY; Li XY; Li M; Zhang GK; Ma FL; Liu ZM; Zhang NY; Meng P
    Zhonghua Nan Ke Xue; 2007 Apr; 13(4):320-3. PubMed ID: 17491264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late-onset hypogonadism in the aging male (LOH): definition, diagnostic and clinical aspects.
    Schubert M; Jockenhövel F
    J Endocrinol Invest; 2005; 28(3 Suppl):23-7. PubMed ID: 16042356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decline of serum levels of free testosterone in aging healthy Chinese men.
    Li JY; Li XY; Li M; Zhang GK; Ma FL; Liu ZM; Zhang NY; Meng P
    Aging Male; 2005; 8(3-4):203-6. PubMed ID: 16390747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the Androgen Deficiency of Aging Men (ADAM) questionnaire useful for the screening of partial androgenic deficiency of aging men?
    Blümel JE; Chedraui P; Gili SA; Navarro A; Valenzuela K; Vallejo S
    Maturitas; 2009 Aug; 63(4):365-8. PubMed ID: 19481382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Andropause in Indian men: a preliminary cross-sectional study.
    Goel A; Sinha RJ; Dalela D; Sankhwar S; Singh V
    Urol J; 2009; 6(1):40-4; discussion 44-6. PubMed ID: 19241341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of screening questionnaires for the diagnosis of hypogonadism.
    Morley JE; Perry HM; Kevorkian RT; Patrick P
    Maturitas; 2006 Mar; 53(4):424-9. PubMed ID: 16140484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are the Aging Male's Symptoms (AMS) scale and the Androgen Deficiency in the Aging Male (ADAM) questionnaire suitable for the screening of late-onset hypogonadism in aging Chinese men?
    Chen W; Liu ZY; Wang LH; Zeng QS; Wang HQ; Sun YH
    Aging Male; 2013 Sep; 16(3):92-6. PubMed ID: 23862578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The reliability of clinical and biochemical assessment in symptomatic late-onset hypogonadism: can a case be made for a 3-month therapeutic trial?
    Black AM; Day AG; Morales A
    BJU Int; 2004 Nov; 94(7):1066-70. PubMed ID: 15541129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The efficacy of testosterone ointment (Glowmin) treatment for late-onset-hypogonadism (LOH) patients according to LOH severity].
    Amano T; Imao T; Takemae K; Iwamoto T; Baba K; Yamakawa K; Nakazawa R; Yoshida K; Sugimori H; Tanaka T; Katabami T; Tanaka M
    Hinyokika Kiyo; 2007 Jan; 53(1):25-9; discussion 29. PubMed ID: 17310765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Update of researches on and utilization of screening questionnaires on late-onset hypogonadism in males].
    Zhou SJ; Gu YQ
    Zhonghua Nan Ke Xue; 2008 Jun; 14(6):555-9. PubMed ID: 18649759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late-onset hypogonadism (LOH) and androgens: validity of the measurement of free testosterone levels in the diagnostic criteria in Japan.
    Iwamoto T; Yanase T; Horie H; Namiki M; Okuyama A
    Int J Urol; 2009 Feb; 16(2):168-74. PubMed ID: 19054164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between testosterone serum levels and lifestyle in aging men.
    Ponholzer A; Plas E; Schatzl G; Struhal G; Brössner C; Mock K; Rauchenwald M; Madersbacher S
    Aging Male; 2005; 8(3-4):190-3. PubMed ID: 16390745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adiponectin and testosterone in patients with symptoms of late-onset hypogonadism: is there a link?
    Tsujimura A; Takada S; Matsuoka Y; Nakayama J; Takao T; Miyagawa Y; Sonoda M; Nishizawa H; Iwahashi H; Funahashi T; Nonomura N; Okuyama A
    Int J Urol; 2009 Oct; 16(10):830-5. PubMed ID: 19719531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of salivary testosterone as a screening test for male hypogonadism.
    Morley JE; Perry HM; Patrick P; Dollbaum CM; Kells JM
    Aging Male; 2006 Sep; 9(3):165-9. PubMed ID: 17050116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum total and bioavailable testosterone levels, central obesity, and muscle strength changes with aging in healthy Chinese men.
    Chu LW; Tam S; Kung AW; Lo S; Fan S; Wong RL; Morley JE; Lam KS
    J Am Geriatr Soc; 2008 Jul; 56(7):1286-91. PubMed ID: 18482300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Change in testosterone concentrations over time is a better predictor than the actual concentrations for symptoms of late onset hypogonadism.
    Holm AC; Fredrikson MG; Theodorsson E; Palmefors LG; Karlsson PS; Joborn C; Hammar ML
    Aging Male; 2011 Dec; 14(4):249-56. PubMed ID: 21627562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between the Saint Louis University ADAM questionnaire and sexual hormonal levels in a male outpatient population over 50 years of age.
    Martínez-Jabaloyas JM; Queipo-Zaragozá A; Rodríguez-Navarro R; Queipo-Zaragozá JA; Gil-Salom M; Chuan-Nuez P
    Eur Urol; 2007 Dec; 52(6):1760-7. PubMed ID: 17590268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study on evaluation methods for serum testosterone level for PADAM diagnosis.
    Tsujimura A; Matsumiya K; Miyagawa Y; Takao T; Fujita K; Takada S; Koga M; Iwasa A; Takeyama M; Okuyama A
    Int J Impot Res; 2005; 17(3):259-63. PubMed ID: 15616608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relevant clinical and biological criteria for the diagnosis of androgen deficiency in the aging male (ADAM)].
    Seisen T; Rouprêt M; Gallais JL; Costa P
    Prog Urol; 2012 Jun; 22 Suppl 1():S21-6. PubMed ID: 22770497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: scientific background and rationale.
    Lunenfeld B; Saad F; Hoesl CE
    Aging Male; 2005 Jun; 8(2):59-74. PubMed ID: 16096160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.